Orencia Arthritis

Links shared publicly online about this topic

Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR

empr.com — “The FDA has approved a subcutaneous formulation of Orencia (abatacept; Bristol-Myers Squibb) for the reduction of signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 1, 2011 at 2:49 pm By:

eMPR MPR Medical Publisher

MPR News: Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis: The FDA has approved a subcutan... http://bit.ly/njnX58

10 months ago...

Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis

medicalnewstoday.com — “Sermo, the world's largest online community for physicians, announced a Sermo Event Report titled Is there any Threat to Anti-TNFs from Newer Biologic DMARDs? In the past year, the FDA has approView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 2, 2010 at 2:06 pm By:

mnt_arthritis MNT Arthritis News Health News

Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis http://mnt.to/3zL8 #arthritis

2 years ago...

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

news-medical.net — “Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 22, 2009 at 4:16 am By:

Lung_Cancer_ News-Medical.Net Health News

Lung Cancer News: Clinical data supports continued development of ORENCIA administration for r.. http://digg.com/u1EoVC

3 years ago...

Bristol-Myers Says ORENCIA Trial Positive for Rheumatoid Arthritis Treatment

emaxhealth.com — “Rheumatoid arthritis (RA) is an autoimmune disease that leads to inflammation of the joints and surrounding tissue causing joint damage and chronic pa...View full resource at emaxhealth.com

  • View Related
  • Share

Most Recently Shared on August 28, 2011 at 7:49 pm By:

Kelly_Young Kelly Young ePatient

@dsymons Yes, that "20% improvement = success" is part of the problem. Ex here para 4: http://t.co/t9NPdmr #rheum

9 months ago...

Dual Sport Life: Good News, Orencia Is Working « Rheumatoid Arthritis Guy

rheumatoidarthritisguy.com — “Dual Sport Life: Good News, Orencia Is Working « Rheumatoid Arthritis GuyView full resource at rheumatoidarthritisguy.com

  • View Related
  • Share

Most Recently Shared on October 23, 2009 at 2:11 pm By:

RA_Guy RA Guy Patient Expert

Dual Sport Life: Good News, Orencia Is Working http://bit.ly/4s3FcJ

3 years ago...

Reliable Sources: Orencia Cough Side Effect & Notions of e-Patients | Reality Check | Rheumatoid Arthritis Warrior

rawarrior.com — “If I cited a percentage of patients who get a cough from Orencia, then I--™d quote a source -- probably a clinical trial. However, if I merely say, as a...View full resource at rawarrior.com

  • View Related
  • Share

Most Recently Shared on March 22, 2011 at 10:00 am By:

Kelly_Young Kelly Young ePatient

Good morning! Today's blog is not just on side effects. It's also about whether what we say here is valid. One... http://fb.me/XWbq7GDJ

1 year ago...

NICE says no to BMS for second-line Orencia | InPharm

inpharm.com — “In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have failedView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 11:35 am By:

Orencia wins expanded European licence | InPharm

inpharm.com — “Orencia wins expanded European licence | InPharmView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on January 27, 2010 at 1:43 pm By:

Pharmafocus Pharmafocus Health News and Pharma

Orencia wins expanded European licence. Bristol-Myers Squibb’s drug can now be used to treat juvenile arthritis. http://ow.ly/10VI5

2 years ago...

Article > NICE final "no" for BM-S' Orencia in RA

pharmatimes.com — “Article > NICE final "no" for BM-S' Orencia in RAView full resource at pharmatimes.com

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 12:30 pm By:

FiercePharma FiercePharma Health Site

Bristol-Myers Squibb's RA drug Orencia got the final thumbs down from U.K. cost-effectiveness agency. http://t.co/JFs85MD $BMY

9 months ago...

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis - Drugs.com MedNews

drugs.com — “European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment oView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 8, 2010 at 10:40 am By:

RA_Wisdom OrganizedWisdom RA OW Health

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after... http://bit.ly/annWwg

2 years ago...

U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis

drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 12:27 am By:

drugscom Drugs.com Health Site

FDA Approves Subcutaneous Formulation of Orencia - http://bit.ly/pjN8oc

10 months ago...

U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis

drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 12:14 am By:

Drugs_Devices Drugs and Devices OW OW Health

U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-A... http://bit.ly/qnjY9u #drug

10 months ago...

Orencia satisfaction and usage data | Monitoring more than 370 patients | Drug safety information | MediGuard

mediguard.org — “Orencia satisfaction and usage data | Monitoring more than 370 patients | Drug safety information | MediGuardView full resource at mediguard.org

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 8:17 pm By:

MediGuard MediGuard.org Health Organization

94% of patients taking #orencia use it for Rheumatoid Arthritis ... http://tinyurl.com/4rkjozx

1 year ago...

Rheumatoid Arthritis - Biologic Medications for Rheumatoid Arthritis: Cimzia vs. Simponi

healthcentral.com — “With nine biologic medications available to treat rheumatoid arthritis, it can be difficult knowing which to choose and how they compare.  Read my previous...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on May 3, 2010 at 2:34 pm By:

LisaEmrich Lisa Emrich Patient Expert

Biologic Medications for RA: Cimzia vs. Simponi - With nine biologic medications available to treat rheumatoid arth... http://ow.ly/17fDbf

2 years ago...

New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy

medicalnewstoday.com — “(NYSE:BMY) announced that new Phase III clinical data show that a weekly subcutaneous injection of an investigational formulation of ORENCIA® (abatacept), following a single intravenous (I.V.)View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 10, 2010 at 5:05 pm By:

mnt_arthritis MNT Arthritis News Health News

New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemn... http://mnt.to/3Mm7

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

  • mnt_arthritis

    MNT Arthritis News

    The latest arthritis / rheumatology news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • Lung_Cancer_

    News-Medical.Net

    Stay up to date with the latest Lung Cancer news and research via News-Medical.Net

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390